Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAGSTONE: Baloxavir in Severe Influenza
NCT03684044Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 28
01
Overview
A Phase 3 trial of baloxavir marboxil in influenza, sponsored by Roche. Started Jan 2019; status: completed.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03684044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03684044.